1. Home
  2. Author
  3. Lelong-Boulouard V

Lelong-Boulouard V

References (2)

Title : Disproportionality analysis in VigiBase as a drug repositioning method for the discovery of potentially useful drugs in Alzheimer's disease - Chretien_2021_Br.J.Clin.Pharmacol_87_2830
Author(s) : Chretien B , Jourdan JP , Davis A , Fedrizzi S , Bureau R , Sassier M , Rochais C , Alexandre J , Lelong-Boulouard V , Dolladille C , Dallemagne P
Ref : British Journal of Clinical Pharmacology , 87 :2830 , 2021
Abstract :
PubMedSearch : Chretien_2021_Br.J.Clin.Pharmacol_87_2830
PubMedID: 33274491

Title : Co-modulation of an allosteric modulator of nicotinic receptor-cholinesterase inhibitor (galantamine) and a 5-HT4 receptor agonist (RS-67333): effect on scopolamine-induced memory deficit in the mouse - Freret_2017_Psychopharmacology.(Berl)_234_2365
Author(s) : Freret T , Lelong-Boulouard V , Lecouflet P , Hamidouche K , Dauphin F , Boulouard M
Ref : Psychopharmacology (Berl) , 234 :2365 , 2017
Abstract :
PubMedSearch : Freret_2017_Psychopharmacology.(Berl)_234_2365
PubMedID: 28631100